 PALO ALTO, Calif., Oct. 6, 2021 PRNewswire -- BridgeBio Pharma, Inc. Nasdaq: BBIO, a commercial-stage biopharmaceutical company that focuses on genetic diseases and cancers, today announced that it will host its second RD Day on Tuesday, October 12, 2021, at 8:30 a.m. 